Acute promyelocytic leukemia, in relapse is a subtype of acute myeloid leukemia characterized by the presence of promyelocytes in the bone marrow and peripheral blood. This condition is clinically significant due to its association with coagulopathy and high mortality rates if not treated promptly. The ICD-10 Code C92.42 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious condition.
ICD-10 Code C92.42 represents Acute promyelocytic leukemia, in relapse, indicating a recurrence of this specific type of leukemia after a period of remission. This code is essential for documenting the patient's clinical status, guiding treatment decisions, and ensuring appropriate billing for healthcare services related to the management of this serious hematological malignancy.
Acute promyelocytic leukemia, in relapse, is caused by genetic mutations leading to the accumulation of promyelocytes in the bone marrow. This condition can progress rapidly, necessitating immediate medical intervention to prevent severe complications such as bleeding and infection. Its management often requires hospitalization and intensive treatment.
ICD-10 Code C92.42 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring that healthcare providers can accurately capture the patient's clinical status and treatment response.
In SOAP notes, ICD-10 Code C92.42 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Acute promyelocytic leukemia, in relapse. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Acute promyelocytic leukemia, in relapse, requires urgent medical intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.42 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential white blood cell count. |
| 88305 | Pathology examination of tissue for diagnosis. |
Common Questions About Using ICD-10 Code C92.42 for Acute promyelocytic leukemia, in relapse
What are the common symptoms of Acute promyelocytic leukemia, in relapse?
Common symptoms include fatigue, fever, easy bruising, and bleeding. Patients may also experience weight loss and night sweats, indicating the need for prompt medical evaluation.
How is Acute promyelocytic leukemia, in relapse treated?
Treatment typically involves chemotherapy with all-trans retinoic acid (ATRA) and arsenic trioxide, along with supportive care to manage complications such as bleeding and infection.
What is the significance of documenting ICD-10 Code C92.42?
Documenting ICD-10 Code C92.42 is crucial for accurate billing, ensuring appropriate treatment plans, and facilitating communication among healthcare providers regarding the patient's condition.
When should this code be used in clinical documentation?
This code should be used when a patient is diagnosed with Acute promyelocytic leukemia, in relapse, particularly after a previous remission, to accurately reflect their current clinical status.
Clinical Notes
SOAP notes
DAP notes
AI medical notes